Friedenberg WR - Search Results

1

Multi-drug resistance in chronic lymphocytic leukemia.

Friedenberg WR, Spencer SK, Musser C, Hogan TF, Rodvold KA, Rushing DA, Mazza JJ, Tewksbury DA, Marx JJ. Friedenberg WR, et al. Leuk Lymphoma. 1999 Jun;34(1-2):171-8. doi: 10.3109/10428199909083394. Leuk Lymphoma. 1999. PMID: 10350346 Clinical Trial.

2

The treatment of older adult patients with acute myeloid leukemia by triple infusion chemotherapy.

Friedenberg WR, Miller HJ, Marx JJ Jr, Schloesser LL, Reding DJ, Mazza JJ, Hocking WG, Mercier RJ, Raich PC, Cassileth PA. Friedenberg WR, et al. Am J Clin Oncol. 1995 Apr;18(2):105-10. doi: 10.1097/00000421-199504000-00003. Am J Clin Oncol. 1995. PMID: 7900701 Clinical Trial.

3

Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group.

Friedenberg WR, Tallman MS, Brodsky I, Paietta E, Rowe JM, Lee SJ, Rowland KM Jr, Schnetzer GW, Reed JC. Friedenberg WR, et al. Leuk Res. 2004 Aug;28(8):813-9. doi: 10.1016/j.leukres.2003.12.002. Leuk Res. 2004. PMID: 15203279 Clinical Trial.

4

Clinical cancer. 5. Progress in acute leukemia.

Mazza J, Friedenberg W. Mazza J, et al. Wis Med J. 1986 Apr;85(4):26-7. Wis Med J. 1986. PMID: 3524032 No abstract available.

5

High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma.

Rushing DA, Friedenberg WR, Baldauf MC, Broste S, Gehlsen JA, Kriesel DH, Koontz DP, Rodvold KA. Rushing DA, et al. Among authors: friedenberg wr. Cancer. 1991 Aug 15;68(4):720-4. doi: 10.1002/1097-0142(19910815)68:4<720::aid-cncr2820680409>3.0.co;2-r. Cancer. 1991. PMID: 1649684

6

Transforming growth factor-beta and multidrug resistance in chronic lymphocytic leukemia.

Friedenberg WR, Salzman SA, Phan SM, Burmester JK. Friedenberg WR, et al. Med Oncol. 1999 Jul;16(2):110-8. doi: 10.1007/BF02785844. Med Oncol. 1999. PMID: 10456659

7

Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group study.

Friedenberg WR, Anderson J, Wolf BC, Cassileth PA, Oken MM. Friedenberg WR, et al. Cancer. 1993 May 15;71(10):2983-9. doi: 10.1002/1097-0142(19930515)71:10<2983::aid-cncr2820711016>3.0.co;2-1. Cancer. 1993. PMID: 8490825 Clinical Trial.

8

Improved treatment of acute nonlymphocytic leukemia in a community hospital--The Marshfield Clinic/St Joseph's Hospital; experience 1974-1981.

Conterato JP, Friedenberg WR, Mazza JJ, Gatlin P, Gehlsen JA, Schloesser LL. Conterato JP, et al. Among authors: friedenberg wr. Wis Med J. 1983 Dec;82(12):17-21. Wis Med J. 1983. PMID: 6582689 No abstract available.

9

The bactericidal defect of neutrophil function with lithium therapy.

Friedenberg WR, Marx JJ. Friedenberg WR, et al. Adv Exp Med Biol. 1980;127:389-99. doi: 10.1007/978-1-4757-0259-0_30. Adv Exp Med Biol. 1980. PMID: 6250336 No abstract available.

10

The effect of lithium carbonate on lymphocyte, granulocyte, and platelet function.

Friedenberg WR, Marx JJ Jr. Friedenberg WR, et al. Cancer. 1980 Jan 1;45(1):91-7. doi: 10.1002/1097-0142(19800101)45:1<91::aid-cncr2820450116>3.0.co;2-#. Cancer. 1980. PMID: 7351009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters